P/E at 64.8 vs Industry's 65.6: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Slight Discount in a Premium Sector

The P/E ratio of Apollo Hospitals Enterprise Ltd. at 64.8 is just below the hospital sector’s average of 65.6, indicating the stock trades at a modest discount relative to its peers. This valuation level suggests that the market is pricing in growth expectations broadly in line with the sector, without a significant premium or discount. Given the sector’s traditionally high valuation multiples, this positioning may reflect investor caution or a recalibration of growth prospects. The market capitalisation stands at a substantial ₹1,27,680.78 crores, underscoring its large-cap status within the hospital sector.

Performance Across Timeframes: Strong Long-Term Gains Amid Short-Term Volatility

Examining the stock’s returns reveals a compelling divergence between short-term and long-term performance. Over the past year, Apollo Hospitals has delivered a robust 21.43% gain, comfortably outperforming the Sensex’s 5.10% loss during the same period. The three-month return is even more impressive at 16.02%, contrasting with the Sensex’s 1.19% decline. This suggests a strong recent momentum, which is further supported by the year-to-date return of 26.09% versus the Sensex’s 8.96% loss.

Shorter-term performance also shows resilience, with a one-month gain of 4.51% compared to the Sensex’s 1.02% rise, and a one-week increase of 1.17% against a flat Sensex. The stock’s one-day gain of 0.67% outperformed the Sensex’s 0.72% decline, signalling continued positive sentiment. However, the stock is currently trading just 1.57% below its 52-week high of ₹9,008.9, indicating it is near peak levels seen in the past year.

This strong performance over multiple timeframes raises the question — previously rated Hold, what is Apollo Hospitals’ current rating? The data suggests a stock that has been steadily gaining ground despite broader market headwinds.

Moving Average Configuration: Bullish Across All Key Levels

The technical picture for Apollo Hospitals is notably positive, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment indicates a strong upward trend across both short and long-term horizons, suggesting sustained buying interest and momentum. The stock has also reversed after two consecutive days of decline, further reinforcing the bullish technical setup.

Such a configuration is often interpreted as a sign of trend continuation rather than a mere recovery or dead-cat bounce — is this a genuine recovery or a relief rally that will fade at the 50 DMA? The data leans towards the former, given the consistent outperformance and strong moving average support.

Sector Performance: Hospital Industry Shows Mixed but Positive Trends

The hospital sector has experienced a mixed performance recently, with some stocks showing flat or negative returns while others have posted gains. Within this context, Apollo Hospitals stands out as one of the sector’s stronger performers, delivering positive returns across all key timeframes. This relative strength highlights the company’s ability to navigate sector challenges effectively.

With the sector’s average P/E at 65.6, the valuation landscape remains elevated, reflecting investor expectations for growth and resilience in healthcare services. The stock’s near-peak price levels and strong technicals suggest it is well-positioned within this environment.

Rating Context: Previously Hold, Now Reassessed

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold, with a Mojo Score of 75.0. The rating was updated on 11 May 2026, reflecting the evolving data landscape. The reassessment takes into account the company’s valuation, strong multi-period performance, and robust technical indicators. This comprehensive approach provides a nuanced view of the stock’s current standing — should investors in Apollo Hospitals hold, buy more, or reconsider?

Long-Term Returns: A Track Record of Outperformance

Looking beyond the recent year, Apollo Hospitals has delivered exceptional returns over the medium and long term. The three-year return stands at 70.83%, vastly outperforming the Sensex’s 14.82%. Over five years, the stock has surged 128.68%, compared to the Sensex’s 48.64%. The decade-long performance is even more striking, with a gain of 565.77% versus the Sensex’s 177.93%.

This sustained outperformance underscores the company’s ability to generate shareholder value over extended periods, reinforcing the valuation premium the market is willing to assign. The question remains — does the current rating reflect this long-term strength adequately?

Conclusion: Data Paints a Picture of Strength with Balanced Valuation

The data for Apollo Hospitals Enterprise Ltd. reveals a stock trading at a valuation closely aligned with its sector, supported by strong performance across multiple timeframes and a bullish technical setup. The company’s large-cap status and consistent outperformance over the long term add further context to its current market standing.

While the valuation does not offer a significant discount, the stock’s near 52-week high and positive momentum suggest confidence among investors. The reassessment of the rating from Hold reflects these dynamics, balancing valuation with performance and technical factors. This comprehensive data-driven view provides a clear lens through which to analyse the stock’s current position and potential trajectory.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today